February 1, 2020

FDA have approved Aimmune Therapeutics

Officials with the FDA have approved Aimmune Therapeutics’ Peanut (Arachis hypogaea) Allergen Powder-dnfp (Palforzia) to mitigate allergic ...

Read More
February 1, 2020

5 things to look out for at Pharmapack

With this year’s Pharmapack set to be bigger than ever, here are some of the biggest trends that are bound to feature at the show. Con ...

Read More
January 30, 2020

Drug supply unaffected by coronavirus says CDMO WuXi biologics

Amid heightened global concern over the recent coronavirus outbreak, Chinese CDMO WuXi Biologics has sought to reassure customers and patients th ...

Read More
January 30, 2020

Key Principles for the Use of Electronic Product Information

EMA, the Heads of Medicines Agencies (HMA) of EU Member States and the European Commission (EC) have published key principles outlining ...

Read More
January 28, 2020

New guideline provides recommendations for UC management

The American Gastroenterological Association (AGA) recently published a new guideline for the medical management of patients with ulcer ...

Read More
January 28, 2020

Coronavirus hysteria in Spain’s Mallorca

PANIC is rife in Spain’s Mallorca as several pharmacies have reported that they have completely sold out of clinical face masks since the o ...

Read More
January 26, 2020

First Meeting of CVMP at the Permanent Office of...

The Committee adopted by consensus a positive opinion for a type II variation application for Innovax-ND-IBD to add a new indication fo ...

Read More
January 24, 2020

Epizyme’s Tazverik receives accelerated approval from US FDA

Epizyme has announced the US Food and Drug Administration (FDA) has granted its epithelioid sarcoma (ES) therapy Tazverik (tazemetostat) accelera ...

Read More
January 24, 2020

AstraZeneca commits to near-zero GWP asthma inhalers

UK pharmaceutical firm AstraZeneca has committed to launching its next-generation asthma and chronic pulmonary disease inhaler with near-zero car ...

Read More